|
|
Phase I COVID-19 Vaccines
This site presents an alphabetically-ordered list of COVID-19 vaccines that are currently in Phase I clinical trials as of July 23, 2022.
Contents:
- ABO1009-DP
- ACM-001
- Ad5-triCoV/Mac
- Almansour-001
- bacTRL-Spike
- Baiya SARS-CoV-2 Vax 1
- ChAdV68-S
- ChAd-triCoV/Mac
- CORVax12
- CoV2 SAM
- CoV2-OGEN1
- CoVepiT
- Covi Vax
- COVID-19 aAPC vaccine
- COVID-19 DNA vaccine by the University of Hong Kong and Immuno Cure 3 Limited
- COVID-19 inactivated vaccine by The Scientific and Technological Research Council of Turkey (TÜBITAK)
- COVIDITY
- COVIGEN
- Covigenix VAX-001
- CV2CoV
- CVXGA1
- CVXGA1
- DoCo-Pro-RBD-1 + MF59
- GRT-R912
- HDT-301
- IN-B009
- LNP-nCoV saRNA-02
- LNP-nCoVsaRNA
- MF59-adjuvanted SARS-CoV-2 Sclamp vaccine
- MIPSCo-mRNA-RBD-1
- MV-014-212
- MVA-SARS-2-S
- naNO-COVID
- NBP2001
- Osvid-19
- Prime-2-CoV-Beta
- RH109
- RQ3013
- RVM-V001
- SC-Ad6-1
- SpFN
- VLPCOV-01
- VXS-1223
- ABO1009-DP
- Clinical trial ID:
- Phase I: NCT05434585
- Age subgroups: 18 years and above
- Location: Indonesia
- Type: mRNA vaccine
- Manufacturer: Suzhou Abogen Biosciences Co., Ltd.
- VIOLIN: 5943
- VO: VO_0005391
- ACM-001
- Clinical trial ID:
- Phase I: NCT05385991
- Age subgroups: 18-55 years
- Location: Australia
- Type: Subunit vaccine
- Manufacturer: ACM Biolabs
- VIOLIN: 5938
- VO: VO_0005392
- Ad5-triCoV/Mac
- Clinical trial ID:
- Phase I: NCT05094609
- Age subgroups: 18-65 years
- Location: Canada
- Type: Recombinant vector vaccine
- Manufacturer: McMaster University
- VIOLIN: 5899
- VO: VO_0005339
- Almansour-001
- Clinical trial ID:
- Phase I: NCT05171946
- Age subgroups: 18-55 years
- Location: Unknown
- Type: DNA vaccine
- Manufacturer: Imam Abdulrahman Bin Faisal University
- VIOLIN: 5920
- VO: VO_0005393
- bacTRL-Spike
- Clinical trial ID:
- Phase I: NCT04334980
- Age subgroups: 18-59 years
- Location: Australia
- Type: DNA vaccine
- Manufacturer: Symvivo
- VIOLIN: 5817
- VO: VO_0005174
- Baiya SARS-CoV-2 Vax 1
- Clinical trial ID:
- Phase I: NCT04953078
- Age subgroups: 18-60 years, 61-75 years
- Location: Unknown
- Type: Subunit vaccine
- Manufacturer: Baiya Phytopharm Co., Ltd.
- VIOLIN: 5878
- VO: VO_0005317
- ChAdV68-S
- Clinical trial ID:
- Phase I: NCT04776317
- Age subgroups: 18-60 years, 61-99 years
- Location: USA
- Type: Recombinant vector vaccine
- Manufacturer: Gritstone Oncology
- VIOLIN: 5845
- VO: VO_0005228
- ChAd-triCoV/Mac
- Clinical trial ID:
- Phase I: NCT05094609
- Age subgroups: 18-65 years
- Location: Canada
- Type: Recombinant vector vaccine
- Manufacturer: McMaster University
- VIOLIN: 5900
- VO: VO_0005342
- CORVax12
- Clinical trial ID:
- Phase I: NCT04627675
- Age subgroups: 18-50 years, 60 years and above
- Location: USA
- Type: DNA vaccine
- Manufacturer: Providence Health & Services, OncoSec Medical Inc.
- VIOLIN: 5820
- VO: VO_0005183
- CoV2 SAM
- Clinical trial ID:
- Phase I: NCT04758962
- Age subgroups: 18-50 years
- Location: USA
- Type: mRNA vaccine
- Manufacturer: GlaxoSmithKline
- VIOLIN: 5842
- VO: VO_0005156
- CoV2-OGEN1
- Clinical trial ID:
- Phase I: NCT04893512
- Age subgroups: 18-56 years
- Location: New Zealand
- Type: Subunit vaccine
- Manufacturer: US Specialty Formulations, VaxForm
- VIOLIN: 5872
- VO: VO_0005263
- CoVepiT
- Clinical trial ID:
- Phase I: NCT04885361
- Age subgroups: 18-45 years
- Location: Belgium
- Type: Subunit vaccine
- Manufacturer: OSE Immunotherapeutics
- VIOLIN: 5870
- VO: VO_0005261
- Covi Vax
- Clinical trial ID:
- Phase I: NCT05128721
- Age subgroups: 18-50 years
- Location: Egypt
- Type: Inactivated or "killed" vaccine
- Manufacturer: National Research Centre, Egypt
- VIOLIN: 5902
- VO: VO_0005349
- COVID-19 aAPC vaccine
- Clinical trial ID:
- Phase I: NCT04299724
- Age subgroups: 6 months to 80 years
- Location: China
- Type: Recombinant vector vaccine
- Manufacturer: Shenzhen Geno-Immune Medical Institute
- VIOLIN: 5821
- VO: VO_0005184
- COVID-19 DNA vaccine by the University of Hong Kong and Immuno Cure 3 Limited
- Clinical trial ID:
- Phase I: NCT05102643
- Age subgroups: 18 to 55 years
- Location: Unknown
- Type: DNA vaccine
- Manufacturer: University of Hong Kong, Immuno Cure 3 Limited
- VIOLIN: 5896
- VO: VO_0005346
- COVID-19 inactivated vaccine by The Scientific and Technological Research Council of Turkey (TÜBITAK)
- Clinical trial ID:
- Phase I: NCT04866069
- Age subgroups: 18-45 years
- Location: Turkey
- Type: Inactivated or "killed" vaccine
- Manufacturer: The Scientific and Technological Research Council of Turkey (TÜBITAK)
- VIOLIN: 5867
- VO: VO_0005257
- COVIDITY
- Clinical trial ID:
- Phase I: NCT05047445
- Age subgroups: 18-59 years
- Location: South Africa
- Type: DNA vaccine
- Manufacturer: Scancell Ltd.
- VIOLIN: 5891
- VO: VO_0005344
- COVIGEN
- Clinical trial ID:
- Phase I: NCT04742842
- Age subgroups: 18-75 years
- Location: Australia
- Type: DNA vaccine
- Manufacturer: University of Sydney, Bionet Co., Ltd, Technovalia
- VIOLIN: 5837
- VO: VO_0005231
- Covigenix VAX-001
- Clinical trial ID:
- Phase I: NCT04591184
- Age subgroups: 18-54 years, 65-84 years
- Location: Canada
- Type: DNA vaccine
- Manufacturer: Entos Pharmaceuticals
- VIOLIN: 5823
- VO: VO_0005186
- CV2CoV
- Clinical trial ID:
- Phase I: NCT05260437
- Age subgroups: 18-64 years, 65 years and above
- Location: USA
- Type: mRNA vaccine
- Manufacturer: CureVac AG
- VIOLIN: 5786
- VO: VO_0005168
- CVXGA1
- Clinical trial ID:
- Phase I: NCT04954287
- Age subgroups: 18-55 years, 56-75 years
- Location: USA
- Type: Recombinant vector vaccine
- Manufacturer: CyanVac LLC
- VIOLIN: 5880
- VO: VO_0005318
- DoCo-Pro-RBD-1 + MF59
- Clinical trial ID:
- Phase I: NCT05272605
- Age subgroups: 18-64 years
- Location: Australia
- Type: Subunit vaccine
- Manufacturer: University of Melbourne
- VIOLIN: 5871
- VO: VO_0005395
- EgyVax
- Clinical trial ID:
- Phase I: NCT05218070
- Age subgroups: 18-55 years
- Location: Egypt
- Type: Inactivated or "killed" vaccine
- Manufacturer: Eva Pharma
- VIOLIN: 5921
- VO: VO_0005396
- GRT-R912
- Clinical trial ID:
- Phase I: NCT05435027
- Age subgroups: 18 years and above
- Location: South Africa
- Type: mRNA vaccine
- Manufacturer: Gritstone Bio, Inc.
- VIOLIN: 5944
- VO: VO_0005397
- HDT-301
- Clinical trial ID:
- Phase I: NCT05132907
- Age subgroups: 18-65 years
- Location: Unknown
- Phase I: NCT04844268
- Age subgroups: 18-55 years
- Location: Unknown
- Type: mRNA vaccine
- Manufacturer: SENAI CIMATEC and HDT Bio
- VIOLIN: 5866
- VO: VO_0005256
- IN-B009
- Clinical trial ID:
- Phase I: NCT05113849
- Age subgroups: 19-55 years
- Location: South Korea
- Type: Subunit vaccine
- Manufacturer: HK inno.N Corporation
- VIOLIN: 5897
- VO: VO_0005351
- LNP-nCoV saRNA-02
- Clinical trial ID:
- Phase I: NCT04934111
- Age subgroups: 18-45 years
- Location: Uganda
- Type: RNA vaccine
- Manufacturer: MRC/UVRI and LSHTM Uganda Research Unit
- VIOLIN: 5875
- VO: VO_0005276
- LNP-nCoVsaRNA
- Other names: COVAC1
- Clinical trial ID:
- Type: RNA vaccine
- Manufacturer: Imperial College London, Morningside Ventures
- Publications:
- McKay et al. Self-amplifying RNA SARS-CoV-2 lipid nanoparticle vaccine candidate induces high neutralizing antibody titers in mice. Nat Commun. 2020; 11(1); 3523. [PubMed: 32647131].
- VIOLIN: 5771
- VO: VO_0005156
- MF59-adjuvanted SARS-CoV-2 Sclamp vaccine
- Clinical trial ID:
- Phase I: NCT04495933
- Age subgroups: 18-55 years, 56 years and above
- Location: Australia
- Type: mRNA vaccine
- Manufacturer: University of Queensland
- Publications:
- Chappell et al. Safety and immunogenicity of an MF59-adjuvanted spike glycoprotein-clamp vaccine for SARS-CoV-2: a randomised, double-blind, placebo-controlled, phase 1 trial. Lancet Infect Dis.. 2021 Apr 19:S1473-3099(21)00200-0. [PubMed: 33887208].
- VIOLIN: 5861
- VO: VO_0005258
- MIPSCo-mRNA-RBD-1
- Clinical trial ID:
- Phase I: NCT05272605
- Age subgroups: 18-64 years
- Location: Australia
- Type: mRNA vaccine
- Manufacturer: University of Melbourne
- VIOLIN: 5927
- VO: VO_0005398
- MV-014-212
- Clinical trial ID:
- Phase I: NCT04798001
- Age subgroups: 18-55 years, 56-69 years
- Unvaccinated Healthy Adults 18-55 years
- Unvaccinated Healthy Adults 56-69 years
- Location: USA
- Type: Live, attenuated vaccine
- Manufacturer: Meissa Vaccines, Inc.
- VIOLIN: 5851
- VO: VO_0005240
- MVA-SARS-2-S
- Clinical trial ID:
- Phase I: NCT04569383
- Age subgroups: 18-55 years
- Location: Germany
- Type: Recombinant vector vaccine
- Manufacturer: Universitätsklinikum Hamburg-Eppendorf, Ludwig-Maximilians - University of Munich
- VIOLIN: 5827
- VO: VO_0005191
- naNO-COVID
- Clinical trial ID:
- Phase I: NCT05113862
- Age subgroups: 18-45 years
- Location: Switzerland
- Type: Subunit vaccine
- Manufacturer: Emergex Vaccines Holding Ltd.
- VIOLIN: 5898
- VO: VO_0005350
- NBP2001
- Clinical trial ID:
- Phase I: NCT04760743
- Age subgroups: 19-55 years
- Location: South Korea
- Type: Subunit vaccine
- Manufacturer: SK Bioscience Co., Ltd.
- VIOLIN: 5844
- VO: VO_0005234
- Osvid-19
- Clinical trial ID:
- Type: Inactivated or "killed" vaccine
- Manufacturer: Osve Pharmaceutical Company
- VIOLIN: 5919
- VO: VO_0005399
- Prime-2-CoV-Beta
- Clinical trial ID:
- Phase I: NCT05389319
- Age subgroups: 18-55 years
- Location: Germany
- Type: Subunit vaccine
- Manufacturer: Speransa Therapeutics
- VIOLIN: 5936
- VO: VO_0005400
- RH109
- Clinical trial ID:
- Phase I: NCT05366296
- Age subgroups: 18-60 years
- Location: China
- Phase I: NCT05351450
- Age subgroups: 18-60 years
- Location: China
- Type: mRNA vaccine
- Manufacturer: Wuhan Recogen Biotechnology Co., Ltd.
- VIOLIN: 5930
- VO: VO_0005401
- RQ3013
- Clinical trial ID:
- Phase I: NCT05394012
- Age subgroups: 18-55 years
- Location: Australia
- Type: mRNA vaccine
- Manufacturer: Walvax Biotechnology, Shanghai RNACure Biopharma
- VIOLIN: 5937
- VO: VO_0005402
- RVM-V001
- Clinical trial ID:
- Phase I: NCT05420077
- Age subgroups: 18-65 years
- Location: Australia
- Type: RNA vaccine
- Manufacturer: RVAC Medicines
- VIOLIN: 5942
- VO: VO_0005403
- SC-Ad6-1
- Clinical trial ID:
- Phase I: NCT04839042
- Age subgroups: 18-55 years
- Location: Australia
- Type: Recombinant vector vaccine
- Manufacturer: Tetherex Pharmaceuticals Corporation
- VIOLIN: 5864
- VO: VO_0005254
- SpFN
- Clinical trial ID:
- Phase I: NCT04784767
- Age subgroups: 18-55 years
- Location: USA
- Type: Subunit vaccine
- Manufacturer: Walter Reed Army Institute of Research
- VIOLIN: 5847
- VO: VO_0005237
- VLPCOV-01
- Clinical trial ID:
- Type: mRNA vaccine
- Manufacturer: VLP Therapeutics Japan GK
- VIOLIN: 5903
- VO: VO_0005352
- VXS-1223
- Clinical trial ID:
- Type: Subunit vaccine
- Manufacturer: Vaxxas Pty Ltd
- VIOLIN: 5932
- VO: VO_0005404
Provenance: All data in Cov19VaxKB originates from manual curation of various resources, including the WHO's COVID-19 Vaccine Tracker.
Note: The page was updated on July 23, 2022. We plan to update this page on a weekly or even a daily basis. Please provide us with any new information that you believe would be useful if included on the website.
|
